18 Dec 2019 Herbal cannabis and pharmaceutical cannabinoid treatment following motor vehicle accidents: A state of the science review
This is a state of the science review produced at the request of the Insurance Corporation of British Columbia (ICBC) to assist in developing funding policy for insurance claims involving the use of herbal cannabis and pharmaceutical cannabinoids for post injury medical management.
Section 1 of the report provides an overall framework for funding policy for ICBC and a summary of clinical trial evidence, harm and pharmacology. Sections 2 to 4, compiled in larger technical reports include details of clinical trial evidence (Section 2); harm (Section 3) and pharmacology (Section 4).
The research on herbal cannabis intoxication as a cause of motor vehicle accidents, while relevant to and important for ICBC, is out of scope for this review.
Click the download button above to view or download the report.
Therapeutics Initiative
Posted at 18:09h, 24 NovemberIssue 115 of the Therapeutics Letter (November 2018) provides a brief overview of pharmaceutical cannabinoids and herbal cannabis and an assessment of the best available evidence for their use in the management of chronic pain. See: https://www.ti.ubc.ca/2018/11/22/115-cannabinoids-for-chronic-pain/